IO Biotech, Inc.
IOBTNASDAQHealthcare
$0.01
$-0.00(-27.59%)
Market Cap$885690
P/E Ratio—
52W High$2.79
52W Low$0.01231
IO Biotech, Inc. (IOBT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IOBT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.07B | $0.07B | $0.05B | $0.03B | $0.01B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Total Operating Expenses | $0.09B | $0.09B | $0.07B | $0.04B | $0.01B |
| Operating Income | ($0.10B) | ($0.09B) | ($0.07B) | ($0.04B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.09B) | ($0.09B) | ($0.07B) | ($0.07B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.10B) | ($0.09B) | ($0.07B) | ($0.07B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.45 | $-1.98 | $-2.48 | $-2.36 | $-1.05 |
| Wtd Avg Shares | 0.07B | 0.04B | 0.03B | 0.03B | 0.01B |
| EBITDA | ($0.09B) | ($0.08B) | ($0.07B) | ($0.07B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more IO Biotech, Inc. data
About IO Biotech, Inc. (IOBT) Income Statement
IO Biotech, Inc. (IOBT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, IOBT reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.10B) — a net profit margin of —.
Frequently asked questions
IOBT · 4 questionsIO Biotech, Inc. (IOBT) reported revenue of $0.00B for 2024, down —% year-over-year.
IOBT revenueIOBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09